ESR1 and breast carcinoma: Previous studies have demonstrated that PR signaling exerts a critical modulatory effect on estrogen receptor alpha (ERα) activity within the breast cancer microenvironment, influencing both tumor biology and therapeutic responsiveness [30–33].